**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 91-66-7 |N,N-Diethylaniline | 99 | 202-088-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T N
Risk Phrases: 23/24/25 33 51/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed. Danger
of cumulative effects. Toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.Dangerous for
the environment.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. May cause
methemoglobinemia, cyanosis (bluish discoloration of skin due to
deficient oxygenation of the blood), convulsions, and death. The
toxicological properties of this substance have not been fully
investigated. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown colored blood.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Methemoglobinemia
is characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. Inhalation of aniline causes anoxia due to the formation of
methemoglobin.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Cool containers with
flooding quantities of water until well after fire is out. Use water
spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 91-66-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.13 mbar @ 20
Viscosity: Not available.
Boiling Point: 215 - 217 deg C @ 760.00mmHg
Freezing/Melting Point: 0 deg C
Autoignition Temperature: 630 deg C ( 1,166.00 deg F)
Flash Point: 85 deg C ( 185.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: IN WATER: 1.4 G/100ML (12C)
Specific Gravity/Density: .9380g/cm3
Molecular Formula: C10H15N
Molecular Weight: 149.24
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 91-66-7: BX3400000
LD50/LC50:
CAS# 91-66-7: Inhalation, rat: LC50 = 1920 mg/m3/4H.
Carcinogenicity:
N,N-Diethylaniline -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: N,N-DIETHYLANILINE
Hazard Class: 6.1
UN Number: 2432
Packing Group: III
IMO
Shipping Name: N,N-DIETHYLANILINE
Hazard Class: 6.1
UN Number: 2432
Packing Group: III
RID/ADR
Shipping Name: N,N-DIETHYLANILINE
Hazard Class: 6.1
UN Number: 2432
Packing group: III
USA RQ: CAS# 91-66-7: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
R 33 Danger of cumulative effects.
R 51/53 Toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 91-66-7: 2
Canada
CAS# 91-66-7 is listed on Canada's DSL List.
CAS# 91-66-7 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 91-66-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/21/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Neodymium chloride hexahydrate, 99.99%
| 13477-89-9 |
|
4-Methylbenzophenone, 97%
| 134-84-9 |
|
4-Biphenylcarbonyl chloride, 98%
| 14002-51-8 |
|
1,4-Dicyanobenzene, 98%
| 623-26-7 |
|
2-Iodophenol
| 533-58-4 |
|
d-alpha-Tocopheryl acid succinate, 99+% (gc)
| 4345-03-3 |
|
2-Cyclopentylidenecyclopentanone, 97%
| 825-25-2 |
|
1,4-Dichloro-2-Iodobenzene, 98%
| 29682-41-5 |
|
6-P-Toluidine-2-Naphthalenesulfonic Acid, 99% (Titr.)
| 7724-15-4 |
|
N,N'-Diethyl-2-Butene-1,4-Diamine, 97%
| 112-21-0 |
|
1-Amino-5,6,7,8-tetrahydronaphthalene, tech., 90%
| 2217-41-6 |
|
N-Ethylbenzylamine, 97%
| 14321-27-8 |
|
Allyl phenoxyacetate, 98+%
| 7493-74-5 |
|
3-Nitrostyrene, 97%
| 586-39-0 |
|
Ruthenium on alumina powder (5% ru)
| |
|
Nipecotamide, 95%
| 4138-26-5 |
|
8-Hydroxy-7-(6-Sulfo-2-Naphthylazo)-5-Quinolinesulfonic Acid Disodium
| 56932-43-5 |
|
Molybdocene Dichloride
| 12184-22-4 |
|
1,2,3,5-Tetramethylbenzene, Tech., 85+%
| 527-53-7 |
|
Androsterone, 97%
| 53-41-8 |
|
1,3-Dimethyl-5-aminoadamantane hydrochloride
| 19982-08-2 |
|
4-Methoxyphenylhydrazine hydrochloride 98%
| 19501-58-7 |
|
2,4,6-Trichloropyrimidine, 99%
| 3764-01-0 |
|
1-Bromo-3-phenylpropane, 98%
| 637-59-2 |
|
Aluminum Tert-Butoxide, 98% (Grav.)
| 556-91-2 |
|
4-Aminothiophenol,96%
| 1193-02-8 |
|
1,2-Dimethyl-3-Hydroxy-4-Pyridone, 99+%
| 30652-11-0 |
|
1,1,1-Tris-(Hydroxymethyl)-Ethane, 97%
| 77-85-0 |
|
4-Benzoylpyridine, 98%
| 14548-46-0 |
|
tert-Butylchlorodiphenylsilane, 98%
| 58479-61-1 |
|
4,4'-Azodianiline, 95% (Titr.)
| 538-41-0 |
|
2-Methyl-5-nitroaniline, 99%
| 99-55-8 |
|
(s)-(-)-1-Benzylglycerol, 98%
| 17325-85-8 |
|
Maleimide, 98%
| 541-59-3 |
|
2-Chlorobenzoxazole, 99% (GC)
| 615-18-9 |
|
Methyl Thiocyanate, 99%
| 556-64-9 |
|
Alpha, 4-Dichloroanisole, 97%
| 21151-56-4 |
|
Lanthanum hexaboride, 99%
| 12008-21-8 |
|
Dl-methyl mandelate, 97%
| 4358-87-6 |
|
(5-z)-9-deoxy-6,9alpha-epoxy-PGF1alpha, sodium salt, 98%, stab. with
| 61849-14-7 |
|
(-)-2-Cyano-6-Phenyloxazolopiperidine, 99+%
| 88056-92-2 |
|
3,4-Dichloroaniline, 98%
| 95-76-1 |
|
Indole, 99+%
| 120-72-9 |
|
3-Methylbenzophenone, 99%
| 643-65-2 |
|
3-Hydroxy-6-Methyl-2-Nitropyridine, 99%
| 15128-90-2 |
|
1,1,3,3-Tetramethyl-2-thiourea, 98%
| 2782-91-4 |
|
1,2-Bis(2-aminophenoxy)-ethane-N,N,N', N'-tetraacetic acid
| 126824-24-6 |
|
6-Amino-5-nitroso-2-thiouracil, 99%
| 1672-48-6 |
|
N,N-Diethylaniline, 99%
| 91-66-7 |
|
Tetraethylammonium tetrafluoroborate, 99%
| 429-06-1 |
|
|